Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoMeasles cases in U.S. by June 30?
Measles cases in U.S. by June 30?
$86,560 Vol.
30 jun 2026
2140
1%
2150
1%
2200
1%
2300
<1%
2400
<1%
$86,560 Vol.
2140
$3,958 Vol.
1%
2150
$32,276 Vol.
1%
2200
$27,847 Vol.
1%
2300
$9,745 Vol.
<1%
2400
$12,733 Vol.
<1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Jun 23, 2026, 2:11 PM ET
Volumen
$86,560Fecha de finalización
30 jun 2026Mercado abierto
Jun 23, 2026, 2:11 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$86,560Fecha de finalización
30 jun 2026Mercado abierto
Jun 23, 2026, 2:11 PM ETResolver
0x65070BE91...Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes